Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction

Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction

Bibliographic Details
Main Authors:	Wei Yongjun, Xiao Ping, Wu Benjuan, Chen Fuxi, Shi Xiaofeng
Format:	Article
Language:	English
Published:	De Gruyter 2023-08-01
Series:	Open Life Sciences
Subjects:	diagnosis sepsis biomarker soluble triggering receptor expressed on myeloid cells-1 soluble suppression of tumorigenicity 2
Online Access:	https://doi.org/10.1515/biol-2022-0639

Similar Items

Diagnostic value of combined detection of serum levels of HMGB1 and sTREM-1 in sepsis complicated with acute kidney injury
by: Lin-lin Sun, et al.
Published: (2024-03-01)

Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
by: Federica Azzolini, et al.
Published: (2022-01-01)

Serum sTREM2: A Potential Biomarker for Mild Cognitive Impairment in Patients With Obstructive Sleep Apnea
by: Xu Jiahuan, et al.
Published: (2022-05-01)

Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
by: Hasan A, et al.
Published: (2020-08-01)

Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure—A Prospective Observational Study
by: Victoria Dworok, et al.
Published: (2023-11-01)

Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Lv Z, et al.
Published: (2023-11-01)

Increased CSF Soluble TREM2 Concentration in Patients With Neurosyphilis
by: Wurong Li, et al.
Published: (2020-02-01)

The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
by: Wendi Huang, et al.
Published: (2023-11-01)

Performance Evaluation of AFIAS ST2 and Ichroma ST2 Assays in Comparison with Presage ST2 Assay
by: Hanah Kim, et al.
Published: (2023-03-01)

Synergistic Effects of Weighted Genetic Risk Scores and Resistin and sST2 Levels on the Prognostication of Long-Term Outcomes in Patients with Coronary Artery Disease
by: Hsin-Hua Chou, et al.
Published: (2022-04-01)

Predictive value of soluble suppression of tumorigenicity 2 in atrial fibrillation: a systematic review and meta-analysis
by: Pengfei Chen, et al.
Published: (2024-01-01)

Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
by: Dong-Hui Huang, et al.
Published: (2016-01-01)

The Diagnostic Value of Soluble Triggering Receptor Expressed on Myeloid Cells for Patients with Acute Stone Pyelonephritis
by: Metin Özsoy, et al.
Published: (2024-04-01)

Soluble suppression of tumorigenicity 2 associated with atrial fibrillation detected after stroke: A retrospective study
by: Wenquan Hou, et al.
Published: (2023-11-01)

sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients
by: Márcio Bezerra-Santos, et al.
Published: (2023-06-01)

Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation
by: Javier García-Seara, et al.
Published: (2023-09-01)

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
by: Elke Boxhammer, et al.
Published: (2022-03-01)

The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort
by: Qixiong Qin, et al.
Published: (2022-06-01)

The soluble suppression of tumorigenicity 2 as a biomarker of early cardiac remodeling in bradycardia patients receiving permanent pacemaker therapy
by: Mohammad Iqbal, et al.
Published: (2023-01-01)

Effects of budesonide combined with noninvasive ventilation on PCT, sTREM-1, chest lung compliance, humoral immune function and quality of life in patients with AECOPD complicated with type II respiratory failure
by: Gao Erxiang, et al.
Published: (2019-03-01)

Early diagnostic and prognostic values of independent and combined detection of presepsin, sTREM-1 and PCT in the in elderly sepsis patients
by: HU Xianjun, et al.
Published: (2023-06-01)

Soluble Suppression of Tumorigenicity‐2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device
by: Lieke Numan, et al.
Published: (2024-01-01)

Impact of Myocardial Ischemia and Revascularization by Percutaneous Coronary Intervention on Circulating Level of Soluble ST2
by: Alkhateeb A, et al.
Published: (2023-07-01)

sTREM2 Differentially Affects Cytokine Expression in Myeloid-Derived Cell Models via MAPK–JNK Signaling Pathway
by: Ryan Arsenault, et al.
Published: (2024-01-01)

Regulation of TREM1-Mediated Inflammation in Hepatocellular Carcinoma Cells
by: Vikrant Rai, et al.
Published: (2021-06-01)

TREM2 regulates innate immunity in Alzheimer’s disease
by: Jiang-Tao Li, et al.
Published: (2018-04-01)

Overexpression of TREM1 is Associated with the Immune-Suppressive Microenvironment and Unfavorable Prognosis in Pan-Cancer
by: Zhou X, et al.
Published: (2023-03-01)

Inhibition of TREM-2 Markedly Suppresses Joint Inflammation and Damage in Experimental Arthritis
by: Alexander B. Sigalov
Published: (2022-08-01)

The therapeutic potential of TREM2 in cancer
by: Elysa M. Wolf, et al.
Published: (2022-09-01)

Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure
by: Stathis Dimitropoulos, et al.
Published: (2020-12-01)

Louki Zupa decoction attenuates the airway inflammation in acute asthma mice induced by ovalbumin through IL-33/ST2-NF-κB/GSK3β/mTOR signalling pathway
by: Xi Huang, et al.
Published: (2022-12-01)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
by: Nergiz Erkut, et al.
Published: (2016-05-01)

Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
by: Yanaika S. Hok-A-Hin, et al.
Published: (2023-05-01)

The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes
by: Anthony V. Serritella, et al.
Published: (2024-01-01)

Assessment of sST2 Behaviors to Evaluate Severity/Clinical Impact of Acute Pulmonary Embolism
by: Luigi Petramala, et al.
Published: (2023-02-01)

Circulating Soluble TREM2 and Cardiovascular Outcome in Cohort Study of Coronary Atherosclerosis Patients
by: Valeri Cuciuc, et al.
Published: (2022-10-01)

Analysis of BCL-2 protein expression in keratinocytic hyperproliferative lesions
by: Abhishek Agrawal, et al.
Published: (2021-12-01)

TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
by: Miguel Moutinho, et al.
Published: (2023-02-01)

Incorporation of Suppression of Tumorigenicity 2 into Random Survival Forests for Enhancing Prediction of Short-Term Prognosis in Community-ACQUIRED Pneumonia
by: Teng Zhang, et al.
Published: (2022-10-01)

Associations of MEFV gene variants, IL-33, and sST2 with the risk of Henoch-Schönlein purpura in children
by: Yang Ruan, et al.
Published: (2024-04-01)